In this article, we discuss how the IL-7/IL-7R pathway can contribute to the development of type 1 diabetes and how preclinical models have demonstrated the efficacy of a selective targeting of this pathway. The gene discussed is IL7R; the disease is type 1 diabetes mellitus.